Form 4 for RGNX REGENXBIO Inc.
Accepted 2022-06-07 00:00:00 ET · period of report 2022-06-03 · accession 0001562180-22-004883 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-06-07 | 2022-06-03 | RGNX | Zachary Jennifer | Dir | A - Grant | $0.00 | +6,020 | 6,020 | New | $0 |
| D | 2022-06-07 | 2022-06-03 | RGNX | Zachary Jennifer | Dir | A - Grant | $0.00 | +29.7K | 29.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-03 | A | A | 6,020 | $0.00 | 6,020 | D | — | — | (F1) Represents shares of common stock underlying a time-based restricted stock unit award (RSU). One-third of the shares subject to this RSU will vest on each of June 1, 2023, June 1, 2024 and June 1, 2025 while the recipient provides continuous service to the Issuer. |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-06-03 | A | A | 29,739 | $0.00 | 29,739 | D | $22.84 · — to 2032-06-03 | 29,739 Common Stock | (F2) The option will vest in equal monthly installments over the 36 months following June 3, 2022 while the optionee provides continuous service to the Issuer. |